|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Drugs Repurposed for Depression nd their In-Silico Studies against P2x7 Receptor |
| Authors Name: | Anita Singh , Komalpreet Kaur , Sakshi Gupta |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_206501
|
| Published Paper Id: | IJNRD2304735 |
| Published In: | Volume 8 Issue 4, April-2023 |
| DOI: | |
| Abstract: | Depression is a typical mental illness that results in a constant feeling of low mood and loss of interest. The major cause of disability in the today's world is depression which also significantly contributes to the overall burden of illness on the population. Drug repurposing is a powerful method for reutilizing the existing medications outside the parameters of their original use and speeding up the development of novel treatment alternatives. The research suggests that drug repurposing is crucial for the quicker and economical development of anti-depressants agents. In this article, reviewed various approved drugs of different classes that can be repurposed as anti-depressants. Also, we conducted in-silico docking studies of various compounds against P2X7 receptor which is now widely being researched for depression for the evaluation of the efficacy of the drugs. |
| Keywords: | Depression, Repurposing, Anti-depressants, Docking, P2X7 receptor |
| Cite Article: | "Drugs Repurposed for Depression nd their In-Silico Studies against P2x7 Receptor", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 4, page no.h275-h281, April-2023, Available :http://www.ijnrd.org/papers/IJNRD2304735.pdf |
| Downloads: | 000118767 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2304735 Registration ID: 206501 Published In: Volume 8 Issue 4, April-2023 DOI (Digital Object Identifier): Page No: h275-h281 Country: Bhimtal, Uttarakhand, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2304735 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2304735 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn